Louis C Bock - Net Worth and Insider Trading

Louis C Bock Net Worth

The estimated net worth of Louis C Bock is at least $256 Million dollars as of 2024-11-13. Louis C Bock is the Director of Horizon Therapeutics PLC and owns about 2,204,465 shares of Horizon Therapeutics PLC (HZNP) stock worth over $256 Million. Louis C Bock is also the Director of Zogenix Inc and owns about 654 shares of Zogenix Inc (ZGNX) stock worth over $17,449. Details can be seen in Louis C Bock's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Louis C Bock has not made any transactions after 2018-03-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Louis C Bock

Louis C Bock Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Louis C Bock owns 6 companies in total, including Zogenix Inc (ZGNX) , Orexigen Therapeutics Inc (OREXQ) , and Scorpius Holdings Inc (SCPX) among others .

Click here to see the complete history of Louis C Bock’s form 4 insider trades.

Insider Ownership Summary of Louis C Bock

Ticker	Comapny	Transaction Date	Type of Owner
ZGNX	Zogenix Inc	2020-05-29	director
OREXQ	Orexigen Therapeutics Inc	2017-07-14	director
SCPX	Scorpius Holdings Inc	2013-09-19	director
		2011-08-02	director
		2010-04-21	10 percent owner
		2004-02-11	director

Louis C Bock Latest Holdings Summary

Louis C Bock currently owns a total of 2 stocks. Among these stocks, Louis C Bock owns 2,204,465 shares of Horizon Therapeutics PLC (HZNP) as of August 2, 2011, with a value of $256 Million and a weighting of 99.99%. Louis C Bock also owns 654 shares of Zogenix Inc (ZGNX) as of March 12, 2018, with a value of $17,449 and a weighting of 0.01%.

Latest Holdings of Louis C Bock

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HZNP	Horizon Therapeutics PLC	2011-08-02	2,204,465	116.30	256,379,280
ZGNX	Zogenix Inc	2018-03-12	654	26.68	17,449

Holding Weightings of Louis C Bock

Louis C Bock Form 4 Trading Tracker

According to the SEC Form 4 filings, Louis C Bock has made a total of 0 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years. The most-recent trade in Horizon Therapeutics PLC is the acquisition of 315,946 shares on August 2, 2011, which cost Louis C Bock around $3 Million.

According to the SEC Form 4 filings, Louis C Bock has made a total of 0 transactions in Zogenix Inc (ZGNX) over the past 5 years. The most-recent trade in Zogenix Inc is the sale of 24,716 shares on March 12, 2018, which brought Louis C Bock around $1 Million.

Insider Trading History of Louis C Bock

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Louis C Bock Trading Performance

GuruFocus tracks the stock performance after each of Louis C Bock's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Louis C Bock is 2.26%. GuruFocus also compares Louis C Bock's trading performance to market benchmark return within the same time period. The performance of stocks bought by Louis C Bock within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Louis C Bock's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Louis C Bock

Average Return

Average return per transaction

Outperforming Transactions

0 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	17.14
Relative Return to S&P 500(%)	17.3

Louis C Bock Ownership Network

Ownership Network List of Louis C Bock

No Data

Ownership Network Relation of Louis C Bock

Louis C Bock Owned Company Details

What does Zogenix Inc do?

Who are the key executives at Zogenix Inc?

Louis C Bock is the director of Zogenix Inc. Other key executives at Zogenix Inc include EVP & CHIEF COMMERCIAL OFFICER Ashish M Sagrolikar , EVP/Chief Development Officer Gail M Farfel , and director & President and CEO Stephen J Farr .

Zogenix Inc (ZGNX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zogenix Inc (ZGNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zogenix Inc (ZGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zogenix Inc (ZGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zogenix Inc Insider Transactions

No Available Data

What does Orexigen Therapeutics Inc do?

Who are the key executives at Orexigen Therapeutics Inc?

Louis C Bock is the director of Orexigen Therapeutics Inc. Other key executives at Orexigen Therapeutics Inc include 10 percent owner Baupost Group Gp, L.l.c. , 10 percent owner Baupost Group Llc/ma , and 10 percent owner Seth A Klarman .

Orexigen Therapeutics Inc (OREXQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Orexigen Therapeutics Inc (OREXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Orexigen Therapeutics Inc (OREXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Orexigen Therapeutics Inc (OREXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Orexigen Therapeutics Inc Insider Transactions

No Available Data

What does Scorpius Holdings Inc do?

Who are the key executives at Scorpius Holdings Inc?

Louis C Bock is the director of Scorpius Holdings Inc. Other key executives at Scorpius Holdings Inc include CFO/Corp Secy William L. Ostrander , director & Chief Executive Officer Jeffrey Alan Wolf , and VP Finance/Controller/Secty Robert James Jakobs .

Scorpius Holdings Inc (SCPX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Scorpius Holdings Inc (SCPX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Scorpius Holdings Inc (SCPX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Scorpius Holdings Inc (SCPX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Scorpius Holdings Inc Insider Transactions

No Available Data

What does Horizon Therapeutics PLC do?

Who are the key executives at Horizon Therapeutics PLC?

Louis C Bock is the director of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .

Horizon Therapeutics PLC (HZNP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Horizon Therapeutics PLC Insider Transactions

No Available Data

What does Alimera Sciences Inc do?

Who are the key executives at Alimera Sciences Inc?

Louis C Bock is the 10 percent owner of Alimera Sciences Inc. Other key executives at Alimera Sciences Inc include 10 percent owner Caligan Partners Lp , other: Chairman Emeritus C. Daniel Myers , and 10 percent owner David Edward Johnson .

Alimera Sciences Inc (ALIM) Insider Trades Summary

Over the past 18 months, Louis C Bock made no insider transaction in Alimera Sciences Inc (ALIM). Other recent insider transactions involving Alimera Sciences Inc (ALIM) include a net sale of 0 shares made by Caligan Partners Lp , and a net purchase of 1,401,901 shares made by Adam Morgan .

In summary, during the past 3 months, insiders sold 0 shares of Alimera Sciences Inc (ALIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 579,000 shares of Alimera Sciences Inc (ALIM) were sold and 1,980,901 shares were bought by its insiders, resulting in a net purchase of 1,401,901 shares.

Alimera Sciences Inc (ALIM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alimera Sciences Inc Insider Transactions

No Available Data

What does Dynavax Technologies Corp do?

Who are the key executives at Dynavax Technologies Corp?

Louis C Bock is the director of Dynavax Technologies Corp. Other key executives at Dynavax Technologies Corp include Principal Accounting Officer Justin Burgess , Chief Medical Officer and VP Robert Janssen , and Senior Vice President David F Novack .

Dynavax Technologies Corp (DVAX) Insider Trades Summary

Over the past 18 months, Louis C Bock made no insider transaction in Dynavax Technologies Corp (DVAX). Other recent insider transactions involving Dynavax Technologies Corp (DVAX) include a net sale of 169,000 shares made by David F Novack , a net sale of 46,327 shares made by Robert Janssen , and a net sale of 3,000,000 shares made by Hack Andrew A. F. .

In summary, during the past 3 months, insiders sold 0 shares of Dynavax Technologies Corp (DVAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,247,529 shares of Dynavax Technologies Corp (DVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,247,529 shares.

Dynavax Technologies Corp (DVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dynavax Technologies Corp Insider Transactions

No Available Data

Louis C Bock Mailing Address

Above is the net worth, insider trading, and ownership report for Louis C Bock. You might contact Louis C Bock via mailing address: C/o Bankamerica Ventures, 950 Tower Lane Ste 700, Foster City Ca 94404.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.